8.13
-0.83 (-9.26%)
| Penutupan Terdahulu | 8.96 |
| Buka | 8.99 |
| Jumlah Dagangan | 89,297 |
| Purata Dagangan (3B) | 37,070 |
| Modal Pasaran | 105,970,328 |
| Harga / Jualan (P/S) | 2.52 |
| Harga / Buku (P/B) | 0.670 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Mar 2025 |
| Margin Keuntungan | -115.91% |
| Margin Operasi (TTM) | -61.41% |
| EPS Cair (TTM) | -3.81 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 169.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.20% |
| Nisbah Semasa (MRQ) | 2.07 |
| Aliran Tunai Operasi (OCF TTM) | -28.87 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -9.90 M |
| Pulangan Atas Aset (ROA TTM) | -14.52% |
| Pulangan Atas Ekuiti (ROE TTM) | -28.48% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Bercampur |
| Diagnostics & Research (Global) | Bercampur | Bercampur | |
| Stok | Prenetics Global Limited | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 2.0 |
| Purata | -0.50 |
|
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by ‘enhancing life through science’. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 19.88% |
| % Dimiliki oleh Institusi | 12.57% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 26 Jun 2025 | Pengumuman | World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder |
| 18 Jun 2025 | Pengumuman | Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction |
| 18 Jun 2025 | Pengumuman | Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board |
| 12 Jun 2025 | Pengumuman | Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |